Impact of Various Tumor Markers in Prognosis of Gastric Cancer -A Hospital Based Study from Tertiary Care Hospital of Kathmandu Valley |
Mittal, Ankush
(Department of Biochemistry, Nepalese Army Institute of Health Sciences)
Gupta, Satrudhan Pd. (Department of Biochemistry, Nepalese Army Institute of Health Sciences) Jha, Dipendra Kumar (Department of Biochemistry, Nepalese Army Institute of Health Sciences) Sathian, Brijesh (Department of Community Medicine, Manipal College of Medical Sciences) Poudel, Bibek (Department of Biochemistry, Manipal College of Medical Sciences) |
1 | Sun Z, Wang ZN, Zhu Z, et al (2012). Evaluation of the seventh edition of American joint committee on cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study. Ann Surg Oncol, 19, 1918-27. DOI ScienceOn |
2 | Zagari RM, Bazzoli F (2004). Gastric cancer: who is at risk? Dig Dis, 22, 302-5. DOI ScienceOn |
3 | Dikshit RP, Mathur G, Mhatre S, et al (2011). Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol, 32, 3. DOI ScienceOn |
4 | Herberman RB (1977). Immunologic tests in diagnosis of cancer. Am J Clin Pathol, 68, 688-98. |
5 | Ishigami S, Natsugoe S, Hokita S, et al (2001). Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol, 32, 41-4. DOI ScienceOn |
6 | Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53, 457-81. DOI ScienceOn |
7 | Jager KJ, van Dijk PC, Zoccali C, et al (2008). The analysis of survival data: the kaplan-meier method. Kidney Int, 74, 560-5. DOI ScienceOn |
8 | Kato K, Taniguchi M, Kawakami T, et al (2011). Gastric Cancer with a Very High Serum CA 19-9 Level. Case Rep Gastroenterol, 5, 258-61. DOI ScienceOn |
9 | Kodera Y, Yamamura Y, Torii A, et al (1996). The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer. Am J Gastroenterol, 91, 49-53. |
10 | Kokociñska D, Jarzab B, Król R, et al (1996). A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers. J Environ Pathol Toxicol Oncol, 15, 283-7. |
11 | Kono K, Amemiya H, Sekikawa T (2002).Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg, 19, 359-65. DOI ScienceOn |
12 | Kuusela P, Haglund C, Roberts PJ, et al (1987). Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. Br J Cancer, 55, 673-6. DOI ScienceOn |
13 | Cox DR (1972). Regression models and life-tables. J R Stat Soc B, 34, 187-220. |
14 | Schauer M, Peiper M, Theisen J, et al (2011). Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment. Eur J Med Res, 16, 29-33. DOI |
15 | Sipponen P, Kekki M, Siurala M(1988). Increased risk of gastric cancer in males affects the intestinal type of cancer and is independent of age, location of the tumour and atrophic gastritis. Br J Cancer, 57, 332-6. DOI |
16 | Bertuccio P, Chatenoud L, Levi F, et al (2009). Recent patterns in gastric cancer: a global overview. Int J Cancer, 125, 666-73. DOI ScienceOn |